AbbVie Presents New Investigational Data for Elagolix at the 2018 American College of Obstetricians and Gynecologists (ACOG) Annual Meeting

- Seven presentations of elagolix data highlight AbbVie's research in endometriosis and uterine fibroids - Primary and secondary efficacy and safety data to be presented from two extension Phase 3 stu...

New Study Finds that 24 Percent of Women Seen in the Obstetrics-Gynecology Setting Met NCCN Guidelines for Hereditary Cancer Genetic Testing

including statements relating to data being presented at the at the 2018 American College of Obstetricians and Gynecologists (ACOG) annual meeting to be held April 27 to 30, 2018 in Austin, TX; proces...

Counsyl Supports New Guidance from the American College of Obstetricians and Gynecologists on Expanded Carrier Screening for Prenatal Genetic Testing

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Counsyl, a DNA testing and genetic counseling service company, welcomes the new carrier screening guidelines issued by the American College of Obstetricia...

AbbVie : Presents New Investigational Data for Elagolix at the 2018 American College of Obstetricians and Gynecologists (ACOG) Annual Meeting

NORTH CHICAGO, Ill., April 27, 2018/PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, in cooperation with Neurocrine Biosciences, Inc. (NASDAQ: NBIX), today announ...